Hong Kong Stock Movement | DualityBio-B (09606.HK) Rises Over 9% as DB-1311 Combined with Pumitamig WCLC Abstract Disclosed, First-Line SCLC ORR Reaches 92.3%

Zhito Finance APP has learned that Duality Biotherapeutics-B (09606.HK) rose more than 9%, up 8.48% as of press time, at HK$183, with a turnover of HK$165 million.